JPWO2025058005A5 - - Google Patents

Info

Publication number
JPWO2025058005A5
JPWO2025058005A5 JP2025545723A JP2025545723A JPWO2025058005A5 JP WO2025058005 A5 JPWO2025058005 A5 JP WO2025058005A5 JP 2025545723 A JP2025545723 A JP 2025545723A JP 2025545723 A JP2025545723 A JP 2025545723A JP WO2025058005 A5 JPWO2025058005 A5 JP WO2025058005A5
Authority
JP
Japan
Prior art keywords
als
subject
biomarker
progression
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025545723A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2025058005A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2024/032644 external-priority patent/WO2025058005A1/ja
Publication of JPWO2025058005A1 publication Critical patent/JPWO2025058005A1/ja
Publication of JPWO2025058005A5 publication Critical patent/JPWO2025058005A5/ja
Pending legal-status Critical Current

Links

JP2025545723A 2023-09-15 2024-09-12 Pending JPWO2025058005A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2023150265 2023-09-15
PCT/JP2024/032644 WO2025058005A1 (ja) 2023-09-15 2024-09-12 筋萎縮性側索硬化症(als)と関連するバイオマーカー

Publications (2)

Publication Number Publication Date
JPWO2025058005A1 JPWO2025058005A1 (https=) 2025-03-20
JPWO2025058005A5 true JPWO2025058005A5 (https=) 2026-01-28

Family

ID=95021397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025545723A Pending JPWO2025058005A1 (https=) 2023-09-15 2024-09-12

Country Status (2)

Country Link
JP (1) JPWO2025058005A1 (https=)
WO (1) WO2025058005A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2504455A4 (en) * 2009-11-24 2013-05-22 Commw Scient Ind Res Org METHODS, KITS AND REAGENTS FOR DIAGNOSIS, DIAGNOSTIC SUPPORT AND / OR MONITORING THE PROGRESS OF A NEUROLOGICAL SENSE
WO2011111043A1 (en) * 2010-03-10 2011-09-15 Yeda Research And Development Co. Ltd Cellular blood markers for early diagnosis of als and for als progression
AU2019264996A1 (en) * 2018-05-10 2020-11-26 The Methodist Hospital Methods for prognosis and management of disease
JP2024536765A (ja) * 2021-09-16 2024-10-08 ザ メソディスト ホスピタル Als療法における使用のための血清免疫ベースのバイオマーカー

Similar Documents

Publication Publication Date Title
Lin et al. Associations between hematological parameters and disease severity in patients with SARS‐CoV‐2 infection
Nalbant et al. Can prognostic nutritional index and systemic immune‐inflammatory index predict disease severity in COVID‐19?
Feng et al. Machine learning algorithm outperforms fibrosis markers in predicting significant fibrosis in biopsy‐confirmed NAFLD
US10408847B2 (en) Tuberculosis biomarkers and uses thereof
Akkina et al. Development of organ‐specific donor risk indices
Andrijevic et al. Interleukin-6 and procalcitonin as biomarkers in mortality prediction of hospitalized patients with community acquired pneumonia
Ura et al. Serum WFA+‐M2 BP is a non‐invasive liver fibrosis marker that can predict the efficacy of direct‐acting anti‐viral‐based triple therapy for chronic hepatitis C
Li et al. Roles of biomarkers in anti‐MDA5‐positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease
Ertem et al. Relation between lymphocyte to monocyte ratio and short‐term mortality in patients with acute pulmonary embolism
Kulkarni et al. Decrements of body mass index are associated with poor outcomes of idiopathic pulmonary fibrosis patients
Da et al. Vibration‐controlled transient elastography for the detection of cirrhosis in chronic hepatitis D infection
Anastasiou et al. Low transferrin and high ferritin concentrations are associated with worse outcome in acute liver failure
Arai et al. Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia
JP2021512568A5 (https=)
Yamanouchi et al. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy
Wang et al. CXCL5 is associated with the increased risk of coronary artery disease
JPWO2025058005A5 (https=)
Hayashi et al. Changes in serum levels of leucine‐rich α2‐glycoprotein predict prognosis in primary biliary cholangitis
Arai et al. Hemosiderin‐laden macrophages in bronchoalveolar lavage: predictive role for acute exacerbation of idiopathic interstitial pneumonias
JP2021523375A5 (https=)
Niu et al. Development of a predictive model for mortality in hospitalized patients with COVID-19
Takikawa et al. Prediction of hepatic encephalopathy development in patients with severe acute hepatitis
WANG et al. Efficacy of transient elastography in screening for large esophageal varices in patients with suspicious or proven liver cirrhosis
Padia et al. Cystatin C and Interleukin‐6 for prognosticating patients with acute decompensation of cirrhosis
Choi et al. Serum neutrophil gelatinase-associated lipocalin at 3 hours after return of spontaneous circulation in patients with cardiac arrest and therapeutic hypothermia: early predictor of acute kidney injury